Viatrexx-Ouch is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Anti-interleukin-1.alpha. Immunoglobulin G Rabbit; Apomorphine; Bryonia Alba Root; Beta-endorphin Human; Arnica Montana; St. John's Wort; Bos Taurus Hypothalamus; Sus Scrofa Hypothalamus; Bos Taurus Limbic System; Sus Scrofa Limbic System; Bos Taurus Nerve; Sus Scrofa Nerve; Bos Taurus Pituitary Gland; Sus Scrofa Pituitary Gland.
Product ID | 73069-402_2651222f-4f0c-42bb-8307-578422597119 |
NDC | 73069-402 |
Product Type | Human Prescription Drug |
Proprietary Name | Viatrexx-Ouch |
Generic Name | Anti-interleukin-1.alpha. Immunoglobulin G Rabbit, Apomorphine, Arnica Montana, Metenkefalin, Bryonia Alba Root, Hypericum Perforatum, Bos Taurus Hypothalamus, Sus Scrofa Hypothalamus, Bos Taurus Limbic System, Sus Scrofa Limbic System, Bos Taurus Nerve, Sus Scrofa Nerve, Bos Taurus Pituitary Gland, Sus Scrofa Pituitary Gland |
Dosage Form | Injection |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS |
Marketing Start Date | 2019-03-29 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | VIATREXX BIO INCORPORATED |
Substance Name | ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; APOMORPHINE; BRYONIA ALBA ROOT; BETA-ENDORPHIN HUMAN; ARNICA MONTANA; ST. JOHN'S WORT; BOS TAURUS HYPOTHALAMUS; SUS SCROFA HYPOTHALAMUS; BOS TAURUS LIMBIC SYSTEM; SUS SCROFA LIMBIC SYSTEM; BOS TAURUS NERVE; SUS SCROFA NERVE; BOS TAURUS PITUITARY GLAND; SUS SCROFA PITUITARY GLAND |
Active Ingredient Strength | 31 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
Pharm Classes | Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-05-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Ingredient | Strength |
---|---|
ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT | 31 [kp_C]/mL |
SPL SET ID: | 2657d606-3073-4f76-9262-3a1b3bffa525 |
Manufacturer | |
UNII | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
73069-402 | Viatrexx-Ouch | anti-interleukin-1.alpha. immunoglobulin g rabbit, apomorphine, arnica montana, metenkefalin, bryonia alba root, hypericum perforatum, bos taurus hypothalamus, sus scrofa hypothalamus, bos taurus limbic system, sus scrofa limbic system, bos taurus nerve, sus scrofa nerve, bos taurus pituitary gland, sus scrofa pituitary gland |
63776-400 | Ouch | anti-interleukin-1.alpha. immunoglobulin g rabbit, apomorphine, arnica montana, metenkefalin, bryonia alba root, hypericum perforatum, bos taurus hypothalamus, sus scrofa hypothalamus, bos taurus limbic system, sus scrofa limbic system, bos taurus nerve, sus scrofa nerve, bos taurus pituitary gland, sus scrofa pituitary gland |
63776-402 | Ouch | anti-interleukin-1.alpha. immunoglobulin g rabbit, apomorphine, arnica montana, metenkefalin, bryonia alba root, hypericum perforatum, bos taurus hypothalamus, sus scrofa hypothalamus, bos taurus limbic system, sus scrofa limbic system, bos taurus nerve, sus scrofa nerve, bos taurus pituitary gland, sus scrofa pituitary gland |